BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34772924)

  • 21. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
    Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
    Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
    J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
    Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
    World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
    Shen G; Lin Y; Yang X; Zhang J; Xu Z; Jia H
    BMC Cancer; 2014 Jun; 14():393. PubMed ID: 24890815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma.
    Wen D; Liu D; Tang J; Dong L; Liu Y; Tao Z; Wan J; Gao D; Wang L; Sun H; Fan J; Wu W
    Tumour Biol; 2015 Aug; 36(8):6211-21. PubMed ID: 25753478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome.
    Li D; Yu T; Hu J; Wu J; Feng S; Xu Q; Zhu H; Zhang X; Zhang Y; Zhou B; Gu L; Zeng Z
    Oxid Med Cell Longev; 2021; 2021():5175581. PubMed ID: 35003516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.
    Wang J; Ding ZW; Chen K; Liu YZ; Li N; Hu MG
    BMC Cancer; 2021 Dec; 21(1):1337. PubMed ID: 34911488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance and function of
    Chen YR; Li YT; Wang MQ; Zhu SL
    Future Oncol; 2021 Nov; 17(33):4457-4470. PubMed ID: 34350781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
    Krishnan MS; Rajan Kd A; Park J; Arjunan V; Garcia Marques FJ; Bermudez A; Girvan OA; Hoang NS; Yin J; Nguyen MH; Kothary N; Pitteri S; Felsher DW; Dhanasekaran R
    Hepatology; 2021 Jun; 73(6):2342-2360. PubMed ID: 33140851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma.
    Zeng L; Fan X; Wang X; Deng H; Zhang X; Zhang K; He S; Li N; Han Q; Liu Z
    BMC Med Genomics; 2020 Oct; 13(1):158. PubMed ID: 33109182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
    Zheng F; Liao YJ; Cai MY; Liu YH; Liu TH; Chen SP; Bian XW; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
    Gut; 2012 Feb; 61(2):278-89. PubMed ID: 21672940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
    Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
    Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
    Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
    Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.